6 results
DEF 14A
MLYS
Mineralys Therapeutics Inc
9 Apr 24
Definitive proxy
7:15am
committee financial expert” as defined by applicable SEC rules and has the requisite financial sophistication as defined under the applicable Nasdaq listing … present. The audit committee is not employed by the Company, nor does it provide any expert assurance or professional certification regarding the Company’s
DRS/A
MLYS
Mineralys Therapeutics Inc
29 Dec 22
Draft registration statement (amended)
12:00am
the applicable rules and regulations of the SEC and Nasdaq. Our board of directors has determined that is an “audit committee financial expert … is appropriate to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters.
Notice to Prospective Investors in Hong
DRS/A
MLYS
Mineralys Therapeutics Inc
7 Dec 22
Draft registration statement (amended)
12:00am
and Nasdaq. Our board of directors has determined that is an “audit committee financial expert” as defined by applicable SEC rules and has the requisite … is appropriate to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters.
Notice to Prospective Investors
DRS
EX-3.2
MLYS
Mineralys Therapeutics Inc
4 Nov 22
Draft registration statement
12:00am
” means all reasonable attorneys fees, retainers, court costs, transcript costs, fees of expert witnesses, private investigators and professional
DRS
EX-10.9
MLYS
Mineralys Therapeutics Inc
4 Nov 22
Draft registration statement
12:00am
that such disclosure is subject to a
protective order limiting access to the disclosure to outside counsel or expert witnesses only. Nothing herein
DRS
mfbur0fbl0xdps
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next